• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA OVATION IX; ILIAC LIMB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA OVATION IX; ILIAC LIMB Back to Search Results
Model Number TV-IL1410140-J
Medical Device Problem Code Material Puncture/Hole (1504)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 07/27/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with an alto stent graft system.Approximately two (2) months post initial procedure a small type 3b endoleak was identified.The patient will undergo a re-intervention, the date to be determined.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with an alto stent graft system.Approximately two (2) months post initial procedure a small type 3b endoleak was identified.The patient will undergo a re-intervention, the date to be determined.Additional information received indicated that the patient did not have an aaa present at time of initial implant (off-label condition) and that the alto system was implanted as treatment of the patient's occlusive disease.The physician has elected to continue monitoring the patient as there is no sac growth.
 
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the reported type 3b endoleak (of the iliac limb) is unconfirmed.This is not consistent with the reported adverse event/incident.The device, user, procedure, or anatomy relatedness of this event could not be determined with the medical records available for review.No procedure-related harms were identified.Potential contributing factors to the event include the following: non-endologix stents previously implanted in the iliacs (off-label concomitant product use), patient had aortoiliac occlusive disease (off-label) and extensive calcifications noted throughout the aorta and iliacs (cautionary product use).The final patient status was discharged home on the first postoperative day in stable condition.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: h6 investigation finding codes; remove 3233.H6 investigation conclusion codes; remove 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
ILIAC LIMB
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
Manufacturer (Section G)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
,
santa rosa CA 95403
Manufacturer Contact
gary kirchgater
3910 brickway blvd
,
santa rosa, CA 95403
8009832284
MDR Report Key15254550
Report Number3008011247-2022-00097
Device Sequence Number6710811
Product Code MIH
UDI-Device Identifier00850007370145
UDI-Public(01)00850007370145(17)250207(10)FS020422-03
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Health Professional,Company Representative
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 07/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/07/2025
Device Model NumberTV-IL1410140-J
Device Lot NumberFS020422-03
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/27/2022
Supplement Date Received by Manufacturer09/20/2022
Initial Report FDA Received Date08/18/2022
Supplement Report FDA Received Date10/04/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/24/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALTO MAIN BODY FS041322-36; OVATION IX ILIAC LIMB FS033022-60; OVATION PRIME FILL POLYMER FF081321-01
Outcome Attributed to Adverse Event Other;
Patient Age64 YR
Patient SexFemale
-
-